Urinary Stone Disease: Progress, Status, and Needs
- PMID: 26190090
- PMCID: PMC4592788
- DOI: 10.1016/j.urology.2015.07.006
Urinary Stone Disease: Progress, Status, and Needs
Abstract
Urinary stone disease (USD) is an important healthcare problem in the US affecting both adults and children, and costs $10 billion to the nation. Prevalence of USD has nearly doubled during the last 15 years in parallel to the obesity and type 2 diabetes epidemic. Despite the advances in the management of an acute episode, one of three stone formers experience recurrence. A better understanding of stone formation is necessary to develop secondary prevention strategies. There are many unanswered research questions that require a multidisciplinary approach. National Institute of Diabetes and Digestive and Kidney Diseases recently held a workshop on USD, and is committed to continue conducting and supporting research in this field.
Published by Elsevier Inc.
References
-
- Cameron MA, Maalouf NM, Adams-Huet B, et al. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol. 2006;17:1422–1428. - PubMed
-
- Maalouf NM, Sakhaee K, Parks JH, et al. Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004;65:1422–1425. - PubMed
-
- Litwin MS, Saigal CS. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Urologic Diseases in America; Washington, DC: 2012. Table 14-47: Economic impact of urologic disease; p. 486. NIH publication 12-7865.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
